Topical immune modulation (TIM): A novel approach to the immunotherapy of systemic disease

Immunology Letters

Volumn 59, Issue 3, 1997, Pages 145-150

  Stricker, Raphael B ^a   Goldberg, Billi ^c   Epstein, William L ^b  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Dinitrochlorobenzene Study Group   (United States)

Author keywords

AIDS; Dinitrochlorobenzene; HIV; Immunotherapy; Topical immune modulation

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN PRESENTATION; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOTHERAPY; LANGERHANS CELL; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC DISEASE; TOPICAL DRUG ADMINISTRATION; VACCINE PRODUCTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; ANTI-HIV AGENTS; DINITROCHLOROBENZENE; DISEASE OUTBREAKS; IMMUNOTHERAPY;

EID: 0030696337     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(97)00114-4     Document Type: Article

References (39)

1. N. Wedroff, Zur frage der dinitrochlorbenzol-dermatosen, Arch. Derm. Syph. 154 (1928) 143-145.
2. N.S. Wedroff, A.P. Dolgoff, Uber die specifische sensibilitat der haut einfachen chemischen stoffen gegenuber, Arch. Derm. Syph. 171 (1935) 641-646.
3. D. Landsteiner, M.W. Chase, Experiments on transfer of cutaneous sensitivity to simple compounds, Proc. Soc. Exp. Biol. Med. 49 (1942) 688-690.
4. M. Sulzberger, A. Rostenberg, Acquired specific supersensitivity to simple chemicals, J. Immunol. 36 (1939) 17-27.
5. W.L. Epstein, A.M. Kligman, The interference phenomenon in allergic contact dermatitis, J. Invest. Dermatol. 31 (1958) 103-106.
6. R.A. Good, W.D. Kelly, J. Rotstein, R.L. Varco, Hodgkin's disease and other lymphomas, Prog. Allergy 6 (1962) 275-291.
7. W.J. Catalano, P.T. Taylor, A.S. Rabson, P.B. Chretien, A method of dinitrochlorobenzene contact sensitization, New Engl. J. Med. 286 (1972) 399-402.
8. R.B. Stricker, B.F. Elswood, D.I. Abrams, Dendritic cells and dinitrochlorobenzene (DNCB): A new treatment approach to AIDS, Immunol. Lett. 29 (1991) 191-196.
9. R. Happle, The potential hazards of dinitrochlorobenzene, Arch. Dermatol. 121 (1985) 330-332.
10. W.G. Dunagin, Potential hazards of dinitrochlorobenzene (DNCB) disputed, Arch. Dermatol. 122 (1986) 11-15.
11. L.B. Mills, Stimulation of T-cellular immunity by cutaneous application of dinitrochlorobenzene, J. Am. Acad. Dermatol. 14 (1986) 1089-1090.
12. C.A.M. Reitmeijer, D.L. Cohn, Severe allergic contact dermatitis from dinitrochlorobenzene in a patient with human immunodeficiency virus infection, Arch. Dermatol. 124 (1988) 490-491.
13. R.B. Stricker, Y.S. Zhu, B.F. Elswood, C. Dumlao, J. Van Elk, T.G. Berger, J. Tappero, W.L. Epstein, D.D. Kiprov, Pilot study of topical dinitrochlorobenzene (DNCB) in human immunodeficiency virus infection, Immunol. Lett. 36 (1993) 1-6.
14. C.E. Mackewicz, H.W. Ortega, J.A. Levy, CDS + cell anti-HIV activity correlates with the clinical state of the infected individual, J. Clin. Invest. 87 (1991) 1462-1466.
15. S. Rowland-Jones, A. McMichael, Cytotoxic T lymphocytes in HIV infection, Semin. Virol. 4 (1993) 83-94.
16. D. Scott-Algara, F. Vuillier, A. Cayota, G. Dighiero, Natural killer (NK) cell activity during HIV infection: a decrease in NK activity is observed at the clonal level and is not restored after in vitro long-term culture of NK cells, Clin. Exp. Immunol. 90 (1992) 181-187.
17. R.B. Stricker, B. Goldberg, L.B. Mills, W.L. Epstein, Decrease in viral load associated with topical dinitrochlorobenzene (DNCB) therapy of HIV disease. Res. Virol. 148 (1997).
18. R.B. Stricker, B.F. Elswood, B. Goldberg, C. Dumlao, J. Van Elk, J. Henry, E.E. Winger, W.L. Epstein, Clinical and immunologic evaluation of HIV-infected patients treated with dinitrochlorobenzene (DNCB), J. Am. Acad. Dermatol. 31 (1994) 462-466.
19. A. Traub, S.B. Margulis, Use of dinitrochlorobenzene (DNCB) as an immune modulator in HIV-positive patients: A pilot study from Brazil, Blood 86 (1995) 935a.
20. R.B. Stricker, B.F. Elswood, Topical dinitrochlorobenzene in HIV disease, J. Am. Acad. Dermatol. 28 (1993) 796-797.
21. S.E. Macatonia, R. Lau, S. Patterson, A.J. Pinching, S.C. Knight, Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology 71 (1990) 38-45.
22. S.C. Knight, S.E. Macatonia, S. Patterson, Infection of dendritic cells with HIV 1: virus load regulates stimulation and suppression of T-cell activity, Res. Virol. 144 (1993) 75-80.
23. S. Patterson, M.S. Roberts, N.R. English, S.E. Macatonia, M.N. Gompels, A.J. Pinching, S.C. Knight, Detection of HIV DNA in peripheral blood dendritic cells of HIV-infected individuals, Res. Virol. 145 (1994) 171-176.
24. R.J. Dearman, I. Kimber, Differential stimulation of immune function by respiratory and contact chemical allergens, Immunology 72 (1991) 563-570.
25. M. Cumberbatch, S.J. Gould, S.W. Peters, D.A. Basketter, R.J. Dearman, I. Kimber, Langerhans cells, antigen presentation, and the diversity of responses to chemical allergens, J. Invest. Dermatol. 99 (1992) 107S-108S.
26. M. Clerici, G.M. Shearer, A Th1-Th2 switch is a critical step in the etiology of HIV infection, Immunol. Today 14 (1993) 107-111.
27. S. Romagnani, E. Maggi, G. Del Prete, An alternative view of the Th1/Th2 switch hypothesis in HIV infection, AIDS Res. Hum. Retroviruses 10 (1994) iii-ix.
28. S. Gupta, B. Vayuvegula, A comprehensive immunological analysis in chronic fatigue syndrome, Scand. J. Immunol. 33 (1991) 319-327.
29. T. Aoki, H. Miyakoshi, Y. Usuda, R.B. Herberman, Low NK syndrome and its relationship to chronic fatigue syndrome, Clin. Immunol. Immunopathol. 69 (1993) 253-265.
30. S.E. Straus, S. Fritz, J.K. Dale, B. Gould, W. Strober, Lymphocyte phenotype and function in the chronic fatigue syndrome, J. Clin. Immunol. 13 (1993) 30-40.
31. G.C. Tsokos, Lymphocyte abnormalities in human lupus, Clin. Immunol. Immunopathol. 63 (1992) 7-9.
32. M. De Carli, M.M. D'Elios, G. Zancuoghi, S. Romagnani, G. Del Prete, Human TH1 and TH2 cells: Functional properties, regulation of development and role in autoimmunity, Autoimmunity 18 (1994) 301-308.
33. R.B. Stricker, B. Goldberg, W.L. Epstein, Immunological alterations in patient with systemic lupus erythematosus treated with topical dinitrochlorobenzene (DNCB), Lancet 345 (1995) 1505-1506.
34. P. Sansonetti, P.H. Lagrange, The immunology of leprosy: Speculations on the leprosy spectrum, Rev. Infect. Dis. 3 (1981) 422-469.
35. Y. Mesret, A.H. Reed, R.C. Howe, Proliferative responses of T cells from the skin and nerve lesions of leprosy patients, Clin. Immunol. Immunopathol. 77 (1995) 243-252.
36. J. Salk, P.A. Bretscher, P.L. Salk, M. Clerici, G.M. Shearer, A strategy for prophylactic vaccination against HIV, Science 260 (1993) 1270-1272.
37. M.F. Good, Harnessing cytotoxic T lymphocytes for vaccine design, Lancet 345 (1995) 999-1000.
38. R.B. Stricker, B. Goldberg, The Maginot line and AIDS vaccines, Med. Hypotheses 48 (1997) 527-529.
39. T. Sato, H.C. Maguire, M.J. Mastrangelo, D. Berd, Human immune response to DNP-modified autologous cells after treatment with a DNP-conjugated melanoma vaccine. Clin. Immunol. Immunopathol. 74 (1995) 35-43.